Hardware, Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
COHR vs IPGP vs LITE vs VIAV vs CIEN
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Communication Equipment
Communication Equipment
Communication Equipment
COHR vs IPGP vs LITE vs VIAV vs CIEN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Semiconductors | Communication Equipment | Communication Equipment | Communication Equipment |
| Market Cap | $50.62B | $4.31B | $63.74B | $11.81B | $76.14B |
| Revenue (TTM) | $1.81T | $1.04B | $2.49B | $1.37B | $5.12B |
| Net Income (TTM) | $191.68B | $29M | $440M | $-55M | $229M |
| Gross Margin | 0.1% | 37.6% | 37.7% | 55.7% | 40.6% |
| Operating Margin | 0.0% | 0.3% | 9.5% | 8.2% | 8.2% |
| Forward P/E | 59.5x | 62.6x | 114.4x | 55.2x | 87.5x |
| Total Debt | $3.89B | $0.00 | $2.61B | $692M | $1.58B |
| Cash & Equiv. | $909M | $404M | $521M | $424M | $1.09B |
COHR vs IPGP vs LITE vs VIAV vs CIEN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Coherent, Inc. (COHR) | 100 | 671.6 | +571.6% |
| IPG Photonics Corpo… (IPGP) | 100 | 65.4 | -34.6% |
| Lumentum Holdings I… (LITE) | 100 | 1217.7 | +1117.7% |
| Viavi Solutions Inc. (VIAV) | 100 | 440.5 | +340.5% |
| Ciena Corporation (CIEN) | 100 | 974.0 | +874.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: COHR vs IPGP vs LITE vs VIAV vs CIEN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
COHR is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 23.4%, EPS growth 71.7%, 3Y rev CAGR 20.5%
- 23.4% revenue growth vs IPGP's 2.7%
- 0.0% yield; the other 4 pay no meaningful dividend
IPGP is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 1.80
- Beta 1.80, current ratio 6.08x
LITE carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 36.4% 10Y total return vs CIEN's 32.3%
- 17.7% margin vs VIAV's -4.0%
- +12.5% vs IPGP's +75.6%
- 8.5% ROA vs VIAV's -2.3%, ROIC -4.3% vs 5.5%
VIAV ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 1.54, Low D/E 88.7%, current ratio 1.50x
- Lower P/E (55.2x vs 114.4x)
- Beta 1.54 vs COHR's 2.79
Among these 5 stocks, CIEN doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.4% revenue growth vs IPGP's 2.7% | |
| Value | Lower P/E (55.2x vs 114.4x) | |
| Quality / Margins | 17.7% margin vs VIAV's -4.0% | |
| Stability / Safety | Beta 1.54 vs COHR's 2.79 | |
| Dividends | 0.0% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +12.5% vs IPGP's +75.6% | |
| Efficiency (ROA) | 8.5% ROA vs VIAV's -2.3%, ROIC -4.3% vs 5.5% |
COHR vs IPGP vs LITE vs VIAV vs CIEN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
COHR vs IPGP vs LITE vs VIAV vs CIEN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LITE leads in 2 of 6 categories
COHR leads 0 • IPGP leads 0 • VIAV leads 0 • CIEN leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LITE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COHR is the larger business by revenue, generating $1.81T annually — 1738.3x IPGP's $1.0B. LITE is the more profitable business, keeping 17.7% of every revenue dollar as net income compared to VIAV's -4.0%. On growth, COHR holds the edge at +1204.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.81T | $1.0B | $2.5B | $1.4B | $5.1B |
| EBITDAEarnings before interest/tax | $913M | $55M | $425M | $207M | $571M |
| Net IncomeAfter-tax profit | $191.7B | $29M | $440M | -$55M | $229M |
| Free Cash FlowCash after capex | -$537.2B | $8M | $399M | $46M | $742M |
| Gross MarginGross profit ÷ Revenue | +0.1% | +37.6% | +37.7% | +55.7% | +40.6% |
| Operating MarginEBIT ÷ Revenue | +0.0% | +0.3% | +9.5% | +8.2% | +8.2% |
| Net MarginNet income ÷ Revenue | +10.6% | +2.8% | +17.7% | -4.0% | +4.5% |
| FCF MarginFCF ÷ Revenue | -29.7% | +0.8% | +16.0% | +3.3% | +14.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1204.5% | +16.6% | +90.1% | +42.8% | +33.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +11190.8% | -54.4% | +3.3% | -70.2% | +2.3% |
Valuation Metrics
Evenly matched — COHR and IPGP each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 139.2x trailing earnings, IPGP trades at a 94% valuation discount to LITE's 2412.9x P/E. On an enterprise value basis, COHR's 48.6x EV/EBITDA is more attractive than LITE's 859.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $50.6B | $4.3B | $63.7B | $11.8B | $76.1B |
| Enterprise ValueMkt cap + debt − cash | $53.6B | $3.9B | $65.8B | $12.1B | $76.6B |
| Trailing P/EPrice ÷ TTM EPS | -613.83x | 139.22x | 2412.94x | 340.33x | 633.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 59.48x | 62.62x | 114.43x | 55.18x | 87.54x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 74.57x | — |
| EV / EBITDAEnterprise value multiple | 48.61x | 48.90x | 859.43x | 90.43x | 169.86x |
| Price / SalesMarket cap ÷ Revenue | 8.71x | 4.30x | 38.75x | 10.89x | 15.96x |
| Price / BookPrice ÷ Book value/share | 5.83x | 2.04x | 54.76x | 14.77x | 28.64x |
| Price / FCFMarket cap ÷ FCF | 262.58x | — | — | 190.52x | 114.44x |
Profitability & Efficiency
Evenly matched — LITE and CIEN each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
LITE delivers a 30.7% return on equity — every $100 of shareholder capital generates $31 in annual profit, vs $-7 for VIAV. COHR carries lower financial leverage with a 0.46x debt-to-equity ratio, signaling a more conservative balance sheet compared to LITE's 2.30x. On the Piotroski fundamental quality scale (0–9), CIEN scores 8/9 vs VIAV's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.9% | +1.4% | +30.7% | -6.9% | +8.3% |
| ROA (TTM)Return on assets | +4.4% | +1.2% | +8.5% | -2.3% | +4.0% |
| ROICReturn on invested capital | +3.6% | +0.6% | -4.3% | +5.5% | +6.9% |
| ROCEReturn on capital employed | +4.2% | +0.6% | -4.8% | +4.9% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 7 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.46x | — | 2.30x | 0.89x | 0.58x |
| Net DebtTotal debt minus cash | $3.0B | -$404M | $2.1B | $269M | $490M |
| Cash & Equiv.Liquid assets | $909M | $404M | $521M | $424M | $1.1B |
| Total DebtShort + long-term debt | $3.9B | $0 | $2.6B | $692M | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 0.01x | — | 9.62x | 2.70x | 3.94x |
Total Returns (Dividends Reinvested)
LITE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LITE five years ago would be worth $107,656 today (with dividends reinvested), compared to $5,151 for IPGP. Over the past 12 months, LITE leads with a +1247.8% total return vs IPGP's +75.6%. The 3-year compound annual growth rate (CAGR) favors LITE at 165.2% vs IPGP's -4.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +64.3% | +35.8% | +131.2% | +181.3% | +118.8% |
| 1-Year ReturnPast 12 months | +358.5% | +75.6% | +1247.8% | +466.6% | +633.9% |
| 3-Year ReturnCumulative with dividends | +892.8% | -12.7% | +1764.2% | +461.0% | +1127.8% |
| 5-Year ReturnCumulative with dividends | +401.6% | -48.5% | +976.6% | +212.0% | +899.2% |
| 10-Year ReturnCumulative with dividends | +1467.0% | +20.2% | +3635.5% | +715.5% | +3230.8% |
| CAGR (3Y)Annualised 3-year return | +114.9% | -4.4% | +165.2% | +77.7% | +130.7% |
Risk & Volatility
Evenly matched — VIAV and CIEN each lead in 1 of 2 comparable metrics.
Risk & Volatility
VIAV is the less volatile stock with a 1.54 beta — it tends to amplify market swings less than COHR's 2.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CIEN currently trades 92.2% from its 52-week high vs IPGP's 65.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.79x | 1.80x | 2.69x | 1.54x | 2.46x |
| 52-Week HighHighest price in past year | $364.80 | $155.82 | $1021.00 | $60.43 | $583.77 |
| 52-Week LowLowest price in past year | $67.30 | $53.98 | $60.38 | $8.87 | $70.77 |
| % of 52W HighCurrent price vs 52-week peak | +87.5% | +65.2% | +87.4% | +84.5% | +92.2% |
| RSI (14)Momentum oscillator 0–100 | 64.4 | 39.7 | 58.8 | 66.7 | 71.3 |
| Avg Volume (50D)Average daily shares traded | 6.8M | 510K | 6.4M | 6.3M | 2.8M |
Analyst Outlook
Evenly matched — IPGP and VIAV each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: COHR as "Buy", IPGP as "Buy", LITE as "Buy", VIAV as "Buy", CIEN as "Buy". Consensus price targets imply 49.2% upside for IPGP (target: $152) vs -37.9% for CIEN (target: $334).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $252.50 | $151.67 | $643.18 | $32.25 | $334.17 |
| # AnalystsCovering analysts | 29 | 27 | 24 | 19 | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.0% | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 0 | 1 | — |
| Dividend / ShareAnnual DPS | $0.07 | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +1.3% | +0.1% | +0.1% | +0.4% |
LITE leads in 2 of 6 categories — strongest in Income & Cash Flow and Total Returns. 4 categories are tied.
COHR vs IPGP vs LITE vs VIAV vs CIEN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is COHR or IPGP or LITE or VIAV or CIEN a better buy right now?
For growth investors, Coherent, Inc.
(COHR) is the stronger pick with 23. 4% revenue growth year-over-year, versus 2. 7% for IPG Photonics Corporation (IPGP). IPG Photonics Corporation (IPGP) offers the better valuation at 139. 2x trailing P/E (62. 6x forward), making it the more compelling value choice. Analysts rate Coherent, Inc. (COHR) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — COHR or IPGP or LITE or VIAV or CIEN?
On trailing P/E, IPG Photonics Corporation (IPGP) is the cheapest at 139.
2x versus Lumentum Holdings Inc. at 2412. 9x. On forward P/E, Viavi Solutions Inc. is actually cheaper at 55. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — COHR or IPGP or LITE or VIAV or CIEN?
Over the past 5 years, Lumentum Holdings Inc.
(LITE) delivered a total return of +976. 6%, compared to -48. 5% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: LITE returned +36. 4% versus IPGP's +20. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — COHR or IPGP or LITE or VIAV or CIEN?
By beta (market sensitivity over 5 years), Viavi Solutions Inc.
(VIAV) is the lower-risk stock at 1. 54β versus Coherent, Inc. 's 2. 79β — meaning COHR is approximately 81% more volatile than VIAV relative to the S&P 500. On balance sheet safety, Coherent, Inc. (COHR) carries a lower debt/equity ratio of 46% versus 2% for Lumentum Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — COHR or IPGP or LITE or VIAV or CIEN?
By revenue growth (latest reported year), Coherent, Inc.
(COHR) is pulling ahead at 23. 4% versus 2. 7% for IPG Photonics Corporation (IPGP). On earnings-per-share growth, the picture is similar: Viavi Solutions Inc. grew EPS 225. 0% year-over-year, compared to 46. 6% for Ciena Corporation. Over a 3-year CAGR, COHR leads at 20. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — COHR or IPGP or LITE or VIAV or CIEN?
Viavi Solutions Inc.
(VIAV) is the more profitable company, earning 3. 2% net margin versus 0. 8% for Coherent, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: COHR leads at 9. 4% versus -10. 9% for LITE. At the gross margin level — before operating expenses — VIAV leads at 56. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is COHR or IPGP or LITE or VIAV or CIEN more undervalued right now?
On forward earnings alone, Viavi Solutions Inc.
(VIAV) trades at 55. 2x forward P/E versus 114. 4x for Lumentum Holdings Inc. — 59. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 49. 2% to $151. 67.
08Which pays a better dividend — COHR or IPGP or LITE or VIAV or CIEN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is COHR or IPGP or LITE or VIAV or CIEN better for a retirement portfolio?
For long-horizon retirement investors, Coherent, Inc.
(COHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1467% 10Y return). Ciena Corporation (CIEN) carries a higher beta of 2. 46 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (COHR: +1467%, CIEN: +32. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between COHR and IPGP and LITE and VIAV and CIEN?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: COHR is a mid-cap high-growth stock; IPGP is a small-cap quality compounder stock; LITE is a mid-cap high-growth stock; VIAV is a mid-cap quality compounder stock; CIEN is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.